← All organizations

Tanvex BioPharma

For profitWebsite ↗

Also known as: Tanvex BioPharma USA, Inc. | TANVEX BIOPHARMA USA INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jun 28, 2024

Timeline

2010s

Jun 1, 2014
Tanvex BioPharma— Founded

2020s

Jun 28, 2024
Filgrastim— Marketing Organization

Drugs by trial phase (4 distinct, 2 trials)

Phase 3 (4 own, 0 via acquisition)

Indications

Studied for

Breast Neoplasms

Marketed drugs (1)

Filgrastim

Recent trials (4)

NCT04109391Lead sponsorPhase 3Aug 23, 2019
NCT04109391Study directorPhase 3Aug 23, 2019
NCT03556358Study directorPhase 3Jun 28, 2018
NCT03556358Lead sponsorPhase 3Jun 28, 2018

Details

Founded: Taipei, TW Jun 1, 2014
Last known activity: Jun 28, 2024